Pediatric tumor microenvironment: developmental dynamics and therapy resistance.

Area of Science:

• Pediatric oncology
• Developmental biology
• Cancer immunology

Background:

• Pediatric cancers arise in unique developmental contexts, differing significantly from adult malignancies.
• The pediatric tumor microenvironment (TME) is shaped by evolving immune systems, stromal dynamics, and developmental factors.
• These specialized niches promote immune evasion, therapy resistance, and disease progression in childhood cancers.

Purpose of the Study:

• To review how developmental processes interact with tumor biology in pediatric cancers.
• To explore mechanisms driving immune evasion and treatment failure in the pediatric TME.
• To highlight advancements and the need for age-informed therapeutic strategies.

Main Methods:

• Literature review focusing on developmental biology and pediatric tumor microenvironments.
• Analysis of key mechanisms like extracellular matrix remodeling, metabolic reprogramming, and epigenetic plasticity.
• Examination of emerging nanomedicine and circulating marker applications.

Main Results:

• Developmental processes critically influence the pediatric TME, fostering tumor growth and immune suppression.
• Extracellular matrix remodeling, metabolic reprogramming, and epigenetic plasticity are key drivers of treatment failure.
• Nanomedicine and circulating markers offer potential for more precise, age-specific interventions.

Conclusions:

• Understanding the pediatric TME's developmental underpinnings is essential for effective cancer treatment.
• Therapeutic strategies must be age-informed, considering the unique risks and benefits of the pediatric TME.
• Integrating developmental biology with tumor ecosystem knowledge is vital for advancing pediatric cancer care.